Recent work has demonstrated that over-expression of glutaredoxin-2 (Glrx2), the thiol oxidoreductase that mediates reversible S-glutathionylation reactions in mitochondria, is a prognostic factor for the survival of patients with colorectal cancer [73]. The gene discussed is GLRX2; the disease is colorectal cancer.